Treatment of acute dermohypodermal infections by pristinamycin: An open study of 42 patients;TRAITEMENT DES DERMOHYPODERMITES AIGUES BACTERIENNES DE L'ADULTE PAR LA PRISTINAMYCINE. ETUDE OUVERTE CHEZ 42 MALADES

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 1, 1996, Pages 16-20

  Bernard, P ^a   Risse, L ^a   Bonnetblanc, J M ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PRISTINAMYCIN; ANTIINFECTIVE AGENT; VIRGINIAMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYSIPELAS; FEMALE; HUMAN; INFLAMMATION; MALE; ORAL DRUG ADMINISTRATION; SKIN INFECTION; STAPHYLOCOCCUS; BACTERIAL SKIN DISEASE; MICROBIOLOGY; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ERYSIPELAS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; TREATMENT OUTCOME; VIRGINIAMYCIN;

EID: 0029865250     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bernard P. Dermo-hypodermal bacterial infections: current concepts. Eur J Med 1992;1:97-104.
2. Bernard P, Bedane C, Mounier M, Denis F, Bonnetblanc JM. Dermohypodermites bactériennes de l'adulte : incidence et place de l'étiologie streptococcique. Ann Dermatol Venereol 1995;122: 495-500.
3. Ronnen M, Suster S, Schevach-Millet M, Modan M. Erysipelas: changing faces. Int J Dermatol 1985;24:169-72.
4. Jorup-Rönstrom C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis 1986;18:519-24.
5. Chartier C, Grosshans E. Erysipelas. Int J Dermatol 1990; 29:459-67.
6. Crickx B, Chevron F, Sigal-Nahum M et coll. Erysipèle : données épidémiologiques, cliniques et thérapeutiques (111 observations). Ann Dermatol Venereol 1991;118:11-6.
7. Bernard P, Denis F, Fayol J, Bonnetblanc JM. Increase in incidence of necrotizing fasciitis is not correlated to that of streptococcal bacteraemia or erysipelas. Dermatologica 1987;175:258-60.
8. Jörup-Rönstiöm C, Britton C, Gavlevick C, Gunnaisson K, Redman AC. The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas. Infection 1984;12:390-4.
9. Hammar H, Wanger L. Erysipelas and necrotizing fasciitis. Br J Dermatol 1985;96:409-19.
10. Lorette G, Py F, Machet L, Vaillant L. Erysipèle : étude rétrospective de 100 cas. Med & Hyg 1990;48:764-8.
11. Bernard P, Plantin P, Roger H et al. Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study. Br J Dermatol 1992;127:155-9.
12. Lanoux P, Penalba C, Legin C, Krivade M, Reveil JC. L'érysipèle. A propos de 118 observations. Med Mal Infect 1993;23:908-12.
13. Bastin R, Rapin M, Kernbaum S. Étude clinique de l'efficacité antistaphylococcique de la pristinamycine et de l'oxacilline. Pathol Biol (Paris) 1982;30:473-5.
14. Denis F, Dabernat H et le Groupe d'Étude Multicentrique. Activités comparées de la pristinamycine et de onze antibiotiques. Étude multicentrique portant sur les bactéries du spectre des streptogramines. Concours Med 1992;114:2293-8.
15. Bernard P, Bedane C, Mounier M, Denis F, Catanzano G, Bonnetblanc JM. Streptococcal cause of erysipelas and cellulitis in adults. Arch Dermatol 1989;125:779-82.
16. Hook EW, Hooton TP, Horton CA et al. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 1986:146:295-7.
17. Hugo-Persson M, Norlin K. Erysipelas and group G streptococci. Infection 1987;15:184-7.
18. Bernard P, Risse L, Mounier M, Bonnetblanc JM. Portage de Staphylococcus aureus : facteur de gravité de l'érysipèle? Ann Dermatol Venereol 1996;123:12-15.
19. Leppard BJ, Seal DV, Colman G, Hallas G. The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas. Br J Dermatol 1985;112:559-67.